Cargando…

Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma

Liver cancer (hepatocellular carcinoma [HCC]) is a fatal cancer worldwide and often is detected at an advanced stage when treatment options are very limited. This drives the development of techniques and platforms for early detection of HCC. In recent years, liquid biopsy has provided a means of non...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyu, Xueying, Tsui, Yu-Man, Ho, Daniel Wai-Hung, Ng, Irene Oi-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048068/ https://www.ncbi.nlm.nih.gov/pubmed/35183803 http://dx.doi.org/10.1016/j.jcmgh.2022.02.008

Ejemplares similares

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids
por: Okajima, Wataru, et al.
Publicado: (2017)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Li, Jie, et al.
Publicado: (2018)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential
por: Tsui, Yu-Man, et al.
Publicado: (2020)

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma
por: Wu, Xiaolin, et al.
Publicado: (2020)

Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone‐Dependent Release of Circulating Tumor DNA
por: Labgaa, Ismail, et al.
Publicado: (2021)

Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013)

Circulating Cell-Free DNA in Inflammatory Bowel Disease: Liquid Biopsies with Mechanistic and Translational Implications
por: Chuah, Cher Shiong, et al.
Publicado: (2023)

Liquid biopsy: blood‐based analyses of circulating cell‐free DNA in xenografts
por: Heidrich, Isabel, et al.
Publicado: (2022)

Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma
por: Tsui, Yu-Man, et al.
Publicado: (2017)

Liquid Biopsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring
por: Shaik, Mohammed Rifat, et al.
Publicado: (2023)

Predicting tumour content of liquid biopsies from cell-free DNA
por: Cardner, Mathias, et al.
Publicado: (2023)

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
por: Ho, Daniel Wai-Hung, et al.
Publicado: (2021)

Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook
por: Ng, Charlotte K. Y., et al.
Publicado: (2018)

Analysis of colorectal cancer‐related mutations by liquid biopsy: Utility of circulating cell‐free DNA and circulating tumor cells
por: Takeda, Kohki, et al.
Publicado: (2019)

Recent Advances in Liquid Biopsy Based on Circulating Tumor DNA
por: Sakuma, Yu, et al.
Publicado: (2019)

Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy
por: Sato, Akemi, et al.
Publicado: (2018)

Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol
por: Sorber, Laure, et al.
Publicado: (2019)

DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies
por: Gonçalves, Emanuel, et al.
Publicado: (2022)

Investigation of Functional Synergism of CENPF and FOXM1 Identifies POLD1 as Downstream Target in Hepatocellular Carcinoma
por: Ho, Daniel Wai-Hung, et al.
Publicado: (2022)

Circulating tumor cells and cell-free tumor DNA analyses in urothelial cancer using the LiquidBiopsy platform
por: Kobayashi, Minoru, et al.
Publicado: (2022)

Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2018)

Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?
por: Yuan, Zuyang, et al.
Publicado: (2020)

Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma
por: Coto-Llerena, Mairene, et al.
Publicado: (2022)

Cell-Free DNA Fragmentomics in Liquid Biopsy
por: Ding, Spencer C., et al.
Publicado: (2022)

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)

Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer
por: Grunvald, Miles W., et al.
Publicado: (2020)

A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA
por: Ottaviano, Margaret, et al.
Publicado: (2021)

Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
por: Mocan, Tudor, et al.
Publicado: (2020)

The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
por: Labgaa, Ismail, et al.
Publicado: (2021)

Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma
por: Yang, Jin-Cui, et al.
Publicado: (2022)

Liquid biopsy for early detection of hepatocellular carcinoma
por: Manea, Ioana, et al.
Publicado: (2023)

Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma
por: Sze, Karen Man‐Fong, et al.
Publicado: (2020)

Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1
por: Zhang, Vanilla Xin, et al.
Publicado: (2021)

Single-Cell Transcriptomics of Liver Cancer: Hype or Insights?
por: Zhang, Qing-yang, et al.
Publicado: (2022)

Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
por: Lee, Jee‐Soo, et al.
Publicado: (2019)

Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies
por: Tellez-Gabriel, Marta, et al.
Publicado: (2020)

Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review
por: Herranz, Raquel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e4vgfhhke8nc9g6q111gp07h3b